The usual treatment of bacterial abscesses, except lung or tubo-ovarian abscesses, includes therapeutic drainage. Increasing evidence suggests that some abscesses respond to antimicrobial therapy without drainage. To study this issue, a MEDLINE search of the literature was performed for cases of bacterial abscess in which treatment without definitive drainage was attempted. Four hundred sixty-five cases were identified. The most commonly involved organs were the liver, brain, and kidney. The success rate of antimicrobial therapy was 85.9%. Factors that predicted a less favorable outcome were abscess diameter of~5 em (odds ratio [OR] = 37.7; P = .0003), involvement of~1 organism (OR = 5.2; P = .014), presence of gram-negative bacilli (OR = 3.4; P = .022), length of therapy of <4 weeks (OR = 49.1; P < .0001), and use of an aminoglycoside as the only active agent (OR = 11.8; P = .008). Many bacterial abscesses can be treated without drainage; abscess size, the organisms involved, and therapy utilized may influence outcome.
The usual treatment of bacterial abscesses, except lung or tubo-ovarian abscesses, includes therapeutic drainage. Increasing evidence suggests that some abscesses respond to antimicrobial therapy without drainage. To study this issue, a MEDLINE search of the literature was performed for cases of bacterial abscess in which treatment without definitive drainage was attempted. Four hundred sixty-five cases were identified. The most commonly involved organs were the liver, brain, and kidney. The success rate of antimicrobial therapy was 85.9%. Factors that predicted a less favorable outcome were abscess diameter of~5 em (odds ratio [OR] = 37.7; P = .0003), involvement of~1 organism (OR = 5.2; P = .014), presence of gram-negative bacilli (OR = 3.4; P = .022), length of therapy of <4 weeks (OR = 49.1; P < .0001), and use of an aminoglycoside as the only active agent (OR = 11.8; P = .008). Many bacterial abscesses can be treated without drainage; abscess size, the organisms involved, and therapy utilized may influence outcome.
Bacterial abscesses usually require drainage for cure. Reasons postulated for the ineffectiveness of antibiotics in the treatment of abscesses include the presence of stationary-phase organisms, low pH, high protein content, the large number of bacteria within abscesses, ionic composition, low oxygen tension, sequestration of bacteria within leukocytes, low abscess zinc concentrations, and the presence of antimicrobial agent-deactivating enzymes [1] . Antimicrobial therapy is generally ineffective in experimental models of suppurative infections when initiation of therapy is delayed for ;?:24 hours [2] .
See the editorial response by Lerner on pages 604-7.
It has long been recognized that lung abscesses respond to prolonged courses of antimicrobials without formal surgical drainage. Since many lung abscesses have air-fluid levels that were observed radiographically, suggesting bronchial communication, it is likely that lung abscesses spontaneously drain via the bronchial tree. It has also been well recognized that most abscesses of the tubo-ovarian region-especially those <8 em in diameter-respond to antimicrobial therapy without the need for surgical drainage [3] , perhaps again because spontaneous drainage occurs via the fallopian tubes.
Since the 1970s there has been an increasing number of reports of other abscesses, especially those involving the brain, liver, and kidney, that have responded to antimicrobial therapy without the need for a drainage procedure. This report reviews the literature regarding medical treatment ofbacterial abscesses in order to determine the extent of the clinical experience documented to date and to define the clinical, microbiological, and therapeutic features of abscesses responding to medical therapy. Since routine initial therapy for lung and tubo-ovarian abscesses no longer includes a drainage procedure, these cases were excluded.
Methods
A MEDLINE search of the literature from 1966 to August 1994 was done to find all English-language reports of bacterial abscesses treated medically, without a therapeutic drainage procedure. Additional cases were included by review of the references of the reports found in the MEDLINE search. Cases were excluded if (1) the cause of the abscess was either a higher bacterium (Nocardia or Actinomyces species) or a mycobacterium, (2) the outcome could not be determined from the report, and (3) medical management was not attempted. When it was evident that the case had been reported more than once, the second report was excluded.
Cases involving small-volume «5 mL) diagnostic aspirations were not excluded, nor were those involving largervolume aspirations if multiple abscesses were present and at least one abscess was not aspirated. In addition, an aspirate of up to 15 mL was acceptable when it was clear from the report that this volume represented <25% ofthe total abscess volume.
For each reported case, a form was completed that included information regarding the clinical and microbiological features of the case, the antimicrobial regimen utilized, and the outcome. A successful outcome was defined as clinical improvement and survival, without the need for therapeutic drainage. Patients were considered to have undergone attempted medical therapy if (1) they were treated for a known bacterial abscess before death and (2) received antimicrobial therapy for at least 24 hours before treatment failure was diagnosed (because of the need for drainage) in cases of clinical deterioration or for at least 72 hours in cases of clinical stability. Groups were compared statistically with a two-tailed Fisher's exact test or a X 2 test.
Results
Four hundred sixty-five cases of abscesses treated medically were found in 138 reports in the literature published from 1966 to August 1994 . Three hundred ninety-nine (85.8%) of these patients were successfully treated without the need for therapeutic drainage. The ages of patients ranged from neonatal to 87 years, with a median age of 31 years.
The organs involved in the 465 patients with bacterial abscesses are shown in table 1. The treatment success rate varied between 80% (in the 55 cases of renal abscesses) and 100% (in the few cases of heart/heart valve, pancreatic, and seminal vesicle abscesses). There was no statistically significant relationship between organ type and treatment success rate (P = .087, X 2 test). The clinical features and abscess characteristics of the 465 patients are shown in table 2. Because this was a literaturereview study and not all reports offered information about the characteristics included in the table, the number of patients analyzed for each feature varied. Data from reports in which these clinical features were described showed that most of the patients were febrile and had pain at the abscess site. The median duration of symptoms was 8 days (range, 1-180 days). The median abscess size was 3 em (range, 0.5-13 em). Ninetyfive patients had multiple abscesses.
One hundred seventy-eight cases had a positive blood culture, a positive gram stain, or growth of organisms in a cultured specimen from either the abscess or a normally sterile contiguous site. Eighteen patients [19, 21, 22, 36, 40, 41, 49, 63, 69, 89, 94, 105, 107, 119, 121, 130, 135, 142] were known to have received antimicrobial therapy when their positive culture specimens were obtained, including abscess aspirates (12) , blood (3), and contiguous-site specimens (5) . Eight patients [20, 29, 46, 47, 68, 79, 108, 141] were known not to be receiving antimicrobial therapy when culture-positive specimens were obtained, including abscess aspirates (1), blood (4), and contiguous-site specimens (3) . The specific timing of antimicrobial therapy and the obtaining of culture specimens could not be ascertained for the remaining 152 patients whose cultures were positive.
In the reports of 169 of the 178 cases involving positive cultures, the specific organism genus was mentioned. One hundred seventy-nine patients were known to have blood cultures performed, and for 92 the results were positive. Sixty-two patients had diagnostic aspirations performed, and cultures of 54 of these aspirates yielded growth. For four patients [5, 48, 80, 89] , the diagnostic aspirate volume was >5 mL (range, 6-15 ml.). Microbiological findings included growth of> 1 organism (14 patients), a single gram-positive aerobe (90), a single gramnegative aerobe (49) , and a single anaerobic organism (16) . It was not possible to determine from the reports the type and adequacy of the microbiological methodology.
Each feature was analyzed, and three correlated with a successful outcome: abscess size of <5 ern, presence of only one bacterial organism, and lack of involvement of aerobic gramnegative bacilli. It is noteworthy that of the 51 cases in which the abscess size was reported to be <5 em, all were successfully treated without therapeutic drainage.
The clinical and microbiological features were analyzed according to the four most commonly involved organs (liver, brain, kidney, and epidural space) and are presented in table 3. More patients with brain or epidural-space involvement had evidence of organ dysfunction than did patients with liver or renal abscesses. Among the patients with brain abscesses, 46 had focal neurological signs or symptoms, 28 had mental status changes, and 16 had seizures. Among the patients with epidural-space infections, 6 had bowel or bladder incontinence, 6 had extremity weakness, 4 had paraplegia or tetraplegia, and 2 had a sensory level. Fifty-eight percent of liver abscesses were~5 em, a feature not noted in any ofthe cases of brain, renal, or epidural abscesses. The outcome for patients with liver abscesses of~5 em was less favorable than for patients with smaller abscesses.
Only a minority of patients had more than one organism isolated. When analyzed according to organ involvement, the lower success rate for polymicrobial infections was statistically significant only for renal abscesses. Although the success rate was lower among all patients with abscesses due to aerobic gram-negative bacilli than among patients whose abscesses did not involve such bacilli, differences did not reach statistical significance when analyzed according to type of organ involvement.
Radiographic procedures indicative of the presence of an abscess are shown in patient. CT, ultrasonography, and nuclear medicine scans were used in the diagnosis of liver, renal, and splenic abscesses. Most of the brain abscesses and all of the subperiosteal orbit abscesses and pancreatic abscesses were diagnosed by CT. Epidural abscesses were diagnosed by CT, MRI scans, and myelography. The organisms isolated from the 169 patients whose cultures yielded microbes are shown in table 5. The most common organisms isolated were Staphylococcus aureus (from 58 of the 169 patients), Escherichia coli (26) , and viridans streptococci (20) . There were marked differences in the bacteria observed in the different organs (tables 3 and 5). Aerobic grampositive, aerobic gram-negative, and anaerobic organisms were equally mixed in liver abscesses. Brain abscesses were due to mostly aerobic gram-positive organisms, especially S. aureus and viridans streptococci, and anaerobes were also frequently observed. Aerobic gram-negative pathogens were most common in renal abscesses, but S. aureus was also observed in 11 of 32 patients. S. aureus was observed in 22 of the 30 patients with epidural abscesses, and Salmonella species were the most frequent isolates from patients with splenic abscesses.
The length of the antimicrobial regimen was documented in 186 of the 465 reports. The median duration of therapy was 42 days, within a range of 3 days to > 1 year. One hundred thirty-seven patients received antimicrobial therapy for >4 weeks, and the outcome was successful for 136. Of the 49 patients who received therapy for ::.=::;4 weeks, it failed for 13 (OR = 49.1; 95% CI, 6.2-388; P < .0001): 7 with liver abscesses, 3 with brain abscesses, and 1 each with a renal, subperiosteal-orbit, and epidural-space abscess. These data may be difficult to interpret, however, since the course of antimicrobial therapy often was discontinued or shortened when its failure was noted. Only one patient clearly relapsed after a short course (10 days) of antimicrobial therapy, and that patient's condition subsequently responded to a 52-day regimen.
Of the 219 cases in which the type of antimicrobial regimen was specified, therapy failed in only 15. Information about the patients treated successfully, classified according to organ involvement, microbial etiology, and antimicrobial usage, is provided in table 6. Forty-four of 47 patients treated with a ,B-lactam drug alone, 59 of 66 patients treated with a ,B-lactam drug plus an aminoglycoside, 75 of 83 patients treated with an aminoglycoside, 20 of 21 patients given metronidazole (often in combination), and 14 of 14 patients given rifampin (often in combination) were treated successfully.
Information about the patients whose medical therapy failed is provided in table 7. Among the 59 patients who received an aminoglycoside as treatment for an abscess of which the microbiological cause was known, medical management failed for 8, and for 4 of these patients the aminoglycoside was the only administered agent noted to be active against at least one of the pathogens (P = .0084; OR = 11.75; 95% CI, 2.1-65.7
[vs. 4 of 51 patients for whom the aminoglycoside was used but was not the only active agent]).
Thirty patients, of which 28 had brain abscesses, were known to have received corticosteroids in addition to antibiotics. The outcome for 29 of these patients was successful (OR = 5.09; 95% CI, 0.68-38.1; P = .102 [vs. the 370 successful outcomes among 435 patients not known to have received corticosteroids]).
Among the reports of the 399 cases treated successfully, 79 provided information regarding the length of therapy before resolution of fever. The median duration of antimicrobial therapy prior to resolution of fever was 5 days (range, 0-49 days). In 23 cases fevers resolved in~2 weeks.
Discussion
The most important information from these data is the large number of abscesses successfully treated without therapeutic drainage. There have been no reports on prospective trials that Although the success rate was 85.8% in this report, it is help determine the likelihood that a patient with a bacterial likely that there was considerable reporting bias. In the 1970s, abscess will respond to medical management. Therefore, it is before the initial reports of successful medical management, it helpful to review the literature, but the information gained must is likely that failures of medical management were not reported be weighed against possible biases.
in the literature. Similarly, since there have been several reports em 1996;23 (September) 
Aerobic gram-positive S. aureus NOTE. In addition, one seminal-vesicle abscess was due to E. coli and one abscess of the subperiosteum of the orbit was due to group A streptococci.
of series of successfully treated cases in the 1990s, it is likely without therapeutic drainage, but the overall likelihood of suethat small numbers of successfully treated cases will no longer cess remains less clear.
be reported. In addition, some clinicians may be less willing Another potential concern is that some cases included in this to report unsuccessfully treated cases. Therefore, it is known review did not represent bacterial abscesses. Abscess formation that a large number of cases have been successfully treated is at the end of a continuum initiated with inflammation and leading to suppuration with capsule formation. Intermediate stages may involve infected phlegmonous tissue with neither frank suppuration nor a fibrous capsule. The diagnosis of abscess was made by the authors of the individual reports on the basis of clinical, radiographic, and microbiological features. Since in most cases material was not available for pathological examination, it may have been difficult for the authors to distinguish bacteria-induced inflammation from an abscess.
It is likely that some of the reports included cases that did not reach the stage of suppuration with fibrous capsule formation, since there are no clinical or radiographic modalities that can reliably distinguish infected tissue from a frank suppurative abscess with capsule formation. Most of the reports were from the era after CT scanning became available, and a CT scan demonstrating an abscess was the most commonly used diagnostic modality.
It is possible that ring enhancement observed on CT scanning is due to inflammation without abscess formation (143] .
Enzmann et al. [144] utilized delayed CT scanning in an attempt to distinguish cerebritis from abscess formation. In patients with cerebritis the magnitude of enhancement remains unchanged for up to 60 minutes, whereas in patients with abscesses the enhancement fades. However, the fade in the enhancement in cases of abscess was not statistically significant in comparison with baseline values, and of the eight patients studied, five would not have been included in this report because their infections were due to higher bacteria, mycobacteria, fungi, or parasites.
Only a minority of patients had microbiologically proven infections, a circumstance that raises the possibility that some of the cases included did not represent bacterial infections. A majority (84.3%) of the cases lacking microbiological documentation of infection (because either cultures were negative or no information was provided) responded to antimicrobial therapy, a value similar to the 88.2% success rate observed in the cases in which the infection was microbiologically proven. NOTE. Amik = amikacin; Amp = ampicillin; ChI = chloramphenicol; Cm = clindamycin; Cthn = cephalothin; Gm = gentamicin; Mtz = metronidazole; Naf = nafcillin; NS = not stated; Pen = penicillin; Sulb = sulbactam; TMP-SMZ = trimethoprim-sulfamethoxazole.
Including only cases of microbiologically proven infection would have been misleading because only a minority ofpatients had positive blood cultures, and aspirations to prove infection were often done only at the time of a drainage procedure because of antimicrobial failure.
The abscesses most commonly treated with medical therapy and without therapeutic drainage involved either the liver or the brain. Heineman et al. suggested in 1971 that brain abscesses may respond to medical therapy [58] . Between 1975 and 1985, 67 cases of brain abscess treated without surgery were reported [145] . Although controversy exists [145] , some investigators have concluded that medical management should be the treatment of choice for multiple abscesses if they are small and if there is no associated major mass effect.
The first case-series report describing the treatment of liver abscesses with medical management alone was by Maher et al. in 1979 [82] . Although it is still controversial, medical management has been suggested as a primary mode of therapy for patients, unless celiotomy is needed for biliary tract disease or to correct an intraabdominal process [146] . Diagnostic percutaneous aspiration may be needed to confirm the diagnosis and to help guide the selection of antimicrobial agents.
Only a small number of heart or heart valve [53, 75, 115, 129] , pancreatic [33, 45] , or seminal vesicle abscesses [68] were reported. The patients with heart or heart valve infections typically had concomitant endocarditis, and the usual diagnostic modality was echocardiography. Five of the six pancreatic abscesses were reported by one author. Recommendations for these types of abscesses, based on this small number of cases, remain speculative.
With the possible exception of one case involving a patient with concomitant hepatic abscesses [99] , all identified cases of intraabdominal abscess involved the liver, spleen, kidney, or pancreas. This suggests that at this time, nonvisceral intraabdominal abscesses are unlikely to respond to medical therapy without drainage. In addition, no cases were found in which medical management of psoas, paraspinous, or intervertebral abscesses was attempted.
In the literature survey, all abscesses <5 em in diameter responded to antimicrobial treatment without therapeutic drain-age; 74.1% of abscesses~5 em in diameter also responded to medical management. Although investigators have commented that abscess size may influence outcome [145, 146] , only in cases of tubo-ovarian abscess has abscess size been demonstrated to influence outcome [147] .
Animal model data have suggested that the encapsulation phase of abscess formation does not begin until 10 days after infection, and is not complete until 14 days after infection [148] . It was postulated that as a result, the outcome for patients presenting earlier in the course of infection-perhaps before the phase of frank: suppuration with encapsulation-may be better. Among the patients in this report, no difference could be found in the outcomes for those treated within 14 days of the onset of symptoms vs. the outcomes for those treated after 14 days. It is still possible, however, that the stage of abscess formation may influence outcome and that the duration of clinical symptoms correlates poorly with the degree of suppuration and encapsulation.
The organisms reported in table 5 are typical of the organisms seen in most cases of abscesses of the liver, brain, kidney, epidural space, heart or heart valves, and pancreas. Only in the cases of splenic abscess, in which eight of 11 patients had infections due to Salmonella species, was a typical microbiological pattern not observed. This raises the likelihood that splenic abscesses due to Salmonella species may be easier to treat with medical management than splenic abscesses due to other organisms.
The use of prior antimicrobial therapy could not be ascertained from the majority of reports; thus, the influence of prior antimicrobial therapy on the type of organisms recovered at the time of aspiration could not be analyzed. It is possible that prior antimicrobial therapy influenced the rate of recovery of organisms and the type of organisms reported in table 5 .
In addition to abscess size, the other clinical variables that predicted a decreased likelihood of success were the isolation of more than one organism and the presence of gram-negative aerobic bacteria. No other reports have made this association. Among anaerobic bacteria, Bacteroides fragilis is highly associated with intraabdominal abscess formation, perhaps secondary to its capsular polysaccharide through mediation with T lymphocytes [149] . Of the six cases involving abscesses due to the B. fragilis group, medical management failed in only one.
Failure of antimicrobial therapy for abscesses may be related to either inadequate antimicrobial concentrations within the abscess or inadequate antimicrobial activity within the abscess milieu. With the exception of the brain, prostate, and aqueous humor, antibiotics penetrate most body tissues [150] . Although there is experimental evidence that the blood-brain barrier is not equivalent to the blood-CSF barrier [151] , most antimicrobials that penetrate the blood-CSF barrier well (such as chloramphenicol, metronidazole, sulfonamides, and rifampin) also enter into brain tissue.
With regard to /3-lactam drugs, most studies have shown adequate concentrations of penicillin in brain abscesses [152] .
Older cephalosporins have been less reliable, but among the newer cephalosporins, moxalactam [153] , cefotaxime [154] , and ceftazidime [155] have all been found in adequate concentrations in brain abscesses. Aminoglycosides penetrate brain abscesses poorly [152] . In a single case report, the vancomycin concentration in a brain abscess was 18 j..tg/mL [156] .
Experimental models have demonstrated well that most antimicrobial agents freely diffuse into abscesses despite the lack of a vascular supply and the presence of a collagen wall [157] . However, the antibiotics may be deactivated by /3-lactamaseproducing organisms [157] . Among the /3-lactam drugs, those that are more resistant to inactivation by /3-lactamases may concentrate better in abscesses [157, 158) .
Although it is likely that antimicrobial concentrations may exceed the MICs for the involved pathogens, there are multiple reasons why antimicrobials may fail to eradicate organisms in an abscess milieu [159] . The low pH, ionic composition, and low oxygen concentration may be inhibitory to antimicrobial activity. Compared with their activity against growth-phase organisms, many antimicrobials-including most /3-lactam drugs-have less activity against the stationary-phase organisms present in a chronic abscess.
Eagle, in 1952, noted that when treatment is delayed for 24 hours, penicillin has less activity in a streptococcal myositis infection model [160] . However, he also noted that when treatment is continued for several days, a cure can be achieved. Aminoglycoside activity may be diminished by avid binding to pus sediment [1] . Sequestration of organisms inside neutrophils may limit the activity of antimicrobials that have little intracellular penetration or activity [161] . Neutrophil proteins such as calprotectin may inhibit but not kill bacteria and render them less susceptible to the bactericidal effects of antibiotics [162, 163] .
In experimental models, some antimicrobial regimens have produced better results in an abscess milieu than others, and these results could not have been predicted on the basis of standard in vitro testing. Metronidazole is more rapidly bactericidal than other agents in a B. fragilis subcutaneous abscess model [164) . Ciprofloxacin plus rifampin is more effective in an E. coli model [165] and significantly more effective in an S. aureus model [166] , as compared with the effectiveness of ciprofloxacin alone. The combination of cefotaxime and amikacin is significantly more effective than either agent alone in an E. coli model [159] .
This literature-review study showed that only 11 patients' therapy failed, among cases in which both the microbiological data and antimicrobial-use data were provided. Seven of these patients were described in the same report [88] . In that report of patients with liver abscesses [88] , it was noted that the abscess tended to be large, none of the abscesses yielded anaerobes (a finding suggesting that appropriate anaerobic cultures were not performed), and aminoglycosides were frequently used without documentation of adequate therapeutic concentrations.
This review also revealed that treatment failed for four of eight patients who received an aminoglycoside as the only em 1996;23 (September) agent with activity against a pathogen, whereas the failure rate was 7.8% (P = .0084) when an aminoglycoside was used but was not the only agent with activity against the offending pathogen(s). Although the number of cases is small, this suggests that aminoglycoside activity in an abscess environment may be suboptimal [1, 159] .
The optimal length of antimicrobial therapy for the treatment of bacterial abscesses has not been defined in comparative human studies. Most authorities tend to use regimens of at least 4-6 weeks, and sometimes longer regimens are utilized. On the basis of the literature-review data, it appears that therapy should probably be administered for >4 weeks; however, many patients were treated with longer regimens.
Use of serial CT scans has also been helpful in decisions about when to stop antimicrobial therapy. Complete resolution of the abscess cavity, mass effect, and contrast enhancement may not occur for 3-4 months, and occasionally contrast enhancement may persist for up to 9 months [148] . In a series of 22 patients with liver abscesses, 55% were found to be febrile at 7 days, and 23% at 14 days, after initiation of antimicrobial therapy [10] . These results are similar to the findings of this literature-review survey, in which the median time to resolution of fever was 5 days but 29% of fevers took~2 weeks to resolve.
In summary, 85.8% of 465 patients with bacterial abscesses (proven or putative) reported in the literature responded to medical management without drainage. Because of reporting biases, this success rate may not be accurate; however, this remains to be determined in a prospective study. Characteristics that predicted a less favorable outcome of medical management included an abscess size of~5 em, the presence of more than one microorganism, the presence of aerobic gram-negative bacilli, and the use of an aminoglycoside as the only active agent against the pathogen(s).
In an era in which interventional radiological techniques and surgical techniques continue to evolve, it remains unclear under which circumstances medical management without drainage is a reasonable option. A disadvantage ofmedical therapy without at least diagnostic drainage is that empirical regimens could be utilized without knowledge of the offending organisms and their antimicrobial susceptibilities.
Comparing the efficacy of surgical therapy to medical therapy was beyond the scope of this report. However, it is likely that therapeutic drainage is preferable for many patients. If therapeutic drainage is believed to involve considerable risk, then prolonged antimicrobial therapy may be an alternative for some patients. There are also situations in which surgical therapy is needed because of the likelihood of tissue destruction or impingement on vital structures, even if bacteriologic cure has or could be achieved medically (for example, in a case of myocardial-valve ring abscess with resultant valvular incompetence).
Future studies should focus on enabling clinicians to better distinguish abscess formation from inflammation by means of noninvasive techniques, to distinguish the characteristics of abscesses that respond to medical management, and to determine the optimal duration and type of therapy.
